Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 8 patents
49 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI113569

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.

A M Feldman, A E Cates, W B Veazey, R E Hershberger, M R Bristow, K L Baughman, W A Baumgartner, and C Van Dop

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Feldman, A. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Cates, A. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Veazey, W. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Hershberger, R. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Bristow, M. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Baughman, K. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Baumgartner, W. in: JCI | PubMed | Google Scholar

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Find articles by Van Dop, C. in: JCI | PubMed | Google Scholar

Published July 1, 1988 - More info

Published in Volume 82, Issue 1 on July 1, 1988
J Clin Invest. 1988;82(1):189–197. https://doi.org/10.1172/JCI113569.
© 1988 The American Society for Clinical Investigation
Published July 1, 1988 - Version history
View PDF
Abstract

Human heart failure is associated with a diminished contractile response to beta-adrenergic agonists. We hypothesized that alterations in the activity of a guanine nucleotide-binding regulatory protein (G protein) might be partially responsible for this abnormality. We therefore measured the activity of G proteins in failing human myocardium utilizing bacterial toxin-catalyzed ADP ribosylation. The activity of a 40,000-mol wt pertussis toxin substrate (alpha G40) was increased by 36% in failing human hearts when compared with nonfailing controls. In contrast, there was no change in the level of the stimulatory regulatory subunit (Gs). The increased activity in alpha G40 was associated with a 30% decrease in basal as well as 5'-guanylyl imidodiphosphate-stimulated adenylate cyclase activity. These data suggest that increased alpha G40 activity is a new marker for failing myocardium and may account at least in part for the diminished responsiveness to beta 1-adrenergic agonists in the failing human heart.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 189
page 189
icon of scanned page 190
page 190
icon of scanned page 191
page 191
icon of scanned page 192
page 192
icon of scanned page 193
page 193
icon of scanned page 194
page 194
icon of scanned page 195
page 195
icon of scanned page 196
page 196
icon of scanned page 197
page 197
Version history
  • Version 1 (July 1, 1988): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 8 patents
49 readers on Mendeley
See more details